Sort
21,453 grants matching “tuberculosis”
Rapid Susceptibility Testing of MDR M. tuberculosis- Phase II
$369,009Myron Sasser · Midi, Inc. · R44 · FY2007 · AI
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis
$368,894Harvey Rubin · University Of Pennsylvania · R01 · FY2008 · AI
The role of antigenic stimulatory strength in the selection and differentiation o
$368,775Matthew A Williams · University Of Utah · R01 · FY2014 · AI
Understanding trehalose synthesis and utilization in mycobacteria
$368,750Donald R Ronning · University Of Toledo · R01 · FY2015 · AI
Understanding trehalose synthesis and utilization in mycobacteria
$368,750Donald R Ronning · University Of Toledo · R01 · FY2014 · AI
Drug Interactions in Substance Abusers with HIV Infection
$368,651Gerald H. Friedland · Yale University · R01 · FY2010 · DA
PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES
$368,621Salama Balume · Dynport Vaccine Company, Llc · N01 · FY2014 · AI
Induction of Th1 Immunity in Tuberculosis
$368,605Padmini Salgame · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2007 · AI
D0CK2 in pleural fibrosis
$368,580Guoqing Qian · University Of Texas Hlth Ctr At Tyler · R01 · FY2024 · HL
HIV/TB INTERACTION IN THE LUNG
$368,514New York University School Of Medicine · R01 · FY2003 · HL
Development of TB Cell Wall Inhibitors
$368,504Colorado State University-Fort Collins · P01 · FY2004 · AI
Impact of Ketone Metabolites on Inflammasome Deactivation in Gout
$368,500Vishwa Deep Dixit · Yale University · R01 · FY2020 · AR
Impact of Ketone Metabolites on Inflammasome Deactivation in Gout
$368,500Vishwa Deep Dixit · Yale University · R01 · FY2019 · AR
Impact of Ketone Metabolites on Inflammasome Deactivation in Gout
$368,500Vishwa Deep Dixit · Yale University · R01 · FY2017 · AR
NEW MEXICO FIVE-YEAR CYCLE PROPOSAL TO FUND TUBERCULOSIS PREVENTION & CONTROL
$368,400Diana Fortune · New Mexico State Department Of Health · U52 · FY2014 · PS
Characterization of an M. tuberculosis vaccine
$368,400University Of Texas Hlth Sci Ctr Houston · R01 · FY2002 · AI
Immune Reconstitution Inflammatory Syndrome in HIV-TB infected patients in Peru
$368,389A. Clinton White · University Of Texas Med Br Galveston · R56 · FY2008 · AI
Peru ICOHRTA Network for AIDS/TB Research Training
$368,347Eduardo Gotuzzo · Universidad Peruana Cayetano Heredia · U2R · FY2008 · TW
Rip Proteins in Innate Immune Signaling
$368,344Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · AI
Group 1 CD1 in Infectious Disease and T Cell Development
$368,330University Of Chicago · R01 · FY2004 · AI
Emerging Infectious Disease and HIV Scholars Program at Brown University
$368,196Silvia Shinpei Chiang · Brown University · R25 · FY2024 · AI
Core B: Integrative Genomics Core
$368,170Soumya Raychaudhuri · Brigham And Women'S Hospital · U19 · FY2021 · AI
South-West European HIV Vaccine Clinical Trial Unit
$368,150Giuseppe Pantaleo · Centre Hospitalier Universitaire Vaudois · U01 · FY2011 · AI
South-West European HIV Vaccine Clinical Trial Unit
$368,149Giuseppe Pantaleo · Centre Hospitalier Universitaire Vaudois · U01 · FY2010 · AI
Role of gammadelta T Cells in Vaccine-Induced Immunity
$368,125Saint Louis University · R01 · FY2002 · AI